Geron Corp (NASDAQ:GERN) - Share price - Overview

Stock Report

Geron Corp GERN

Last Price
$3.92

Day Change
-0.10|-2.49%

As of 19/06/2018
19:05:04 EDT | USD
Minimum 15 Minutes Delay.

Last Close4.02
Day Range3.83 - 3.97
Mkt Cap678.50Mil
52-Wk Range1.74 - 6.68
Yield %-
ISINUS3741631036
Volume3,375,738
P/E-23.06
P/S714.29
P/CF-30.34

Share Price

Financials
201520162017
More ...
Income Statement
Revenue36.376.161.07
Operating Income0.75-30.65-29.26
Net Income0.05-29.54-27.92
Basic EPS0.00-0.19-0.18
Avg. Diluted Shares Outstanding163159159
Balance Sheet
Current Assets115.89116.1195.97
Non Current Assets32.8714.1414.34
Total Assets148.76130.25110.31
Current Liabilities6.637.876.52
Total Liabilities---
Total Equity142.13122.38103.80
Cash Flow
Operating Cash Flow-24.20-18.37-20.56
Capital Expenditure-0.09-0.06-
Free Cash Flow-24.29-18.43-

In millions, except "Basic EPS". Currency is USD.

Company Profile

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

18
Key Stats
More ...
Price/Earning TTM-23.65
Price/Book6.88
Price/Sales TTM600.00
Rev Growth (3 year avg)-2.61
EPS Growth (3 year avg)-
Operating Margin % TTM-2,746.95
Net Margin % TTM-2,621.22
ROE TTM-24.69
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.